FDA Approved: IMFINZI — Original Application (AstraZeneca Pharmaceuticals LP)

View source ↗

Summary

The FDA approved the original application for Imfinzi (durvalumab) from AstraZeneca, marking its first approved indication.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• IMFINZI (DURVALUMAB)

Snippet

ORIG AP for IMFINZI (DURVALUMAB)